How a TEDCO portfolio company, Adaptive Phage Therapeutics, is saving lives with bacteria-killing viruses
Dr. Carl Merril began researching bacteria-killing viruses at National Institutes of Health in 1965, leading to a partnership with the U.S. Navy’s biological defense group to combat potential bioterrorism attacks with superbugs.
LEARN MORE